𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines

✍ Scribed by Lisa M. Adler; Thomas J. Herzog; Sybilann Williams; Janet S. Rader; David G. Mutch

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
723 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Quantitative proteome analysis of multid
Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line
✍ Sang-Lin Li; Feng Ye; Wei-Jun Cai; Huai-Dong Hu; Peng Hu; Hong Ren; Fu-Fan Zhu; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 271 KB

## Abstract In order to understand the molecular mechanisms of multidrug resistance (MDR) in ovarian cancer, we employed the proteomic approach of isobaric tags for relative and absolute quantification (iTRAQ), followed by LC‐MS/MS, using the cisplatin‐resistant COC1/DDP cell line and its parental

Schedule-dependent interaction of doxoru
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
✍ Wainer Zoli; Luca Ricotti; Fabio Barzanti; Monica Dal Susino; Giovanni Luca Fras πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 106 KB πŸ‘ 2 views

We showed previously that a sequential treatment with doxorubicin (4 hr) followed by paclitaxel (24 hr) (Dox=Pacl) induces a synergistic cytotoxic effect in the BRC-230 breast cancer cell line and in human primary breast cancer cultures. The validity of this experimental finding was confirmed in a c